References
- Gorelick PB. The global burden of stroke: persistent and disabling. Lancet Neurol. 2019;18(5):417–418. https://doi.org/https://doi.org/10.1016/S1474-4422(19)30030-4.
- Sabih A, Tadi P, Kumar A. Stroke prevention. In: StatPearls Internet. Treasure Island (FL): StatPearls Publishing; 2020 January.
- Wu X, Zhou Q, Chen Q, et al. Association of homocysteine level with risk of stroke: a dose-response meta-analysis of prospective cohort studies. Nutr Metab Cardiovasc Dis. 2020;30(11):1861–1869. https://doi.org/https://doi.org/10.1016/j.numecd.2020.07.026.
- Spence JD. Homocysteine lowering for stroke prevention: unravelling the complexity of the evidence. Int J Stroke. 2016;11:744–747. https://doi.org/https://doi.org/10.1177/1747493016662038.
- Martí-Carvajal AJ, Solà I, Lathyris D, et al. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev. 2017; 8(8):CD006612. https://doi.org/https://doi.org/10.1002/14651858.CD006612.pub5.
- Harris S, Rasyid A, Kurniawan M, et al. Association of high blood homocysteine and risk of increased severity of ischemic stroke events. Int J Angiol. 2019;28(1):34–38. https://doi.org/https://doi.org/10.1055/s-0038-1667141.
- Markišić M, Pavlović AM, Pavlović DM. The Impact of homocysteine, vitamin B12, and vitamin D levels on functional outcome after first-ever ischaemic stroke. Biomed Res Int. 2017;2017:5489057.
- Yao ES, Tang Y, Xie MJ, et al. Elevated homocysteine level related to poor outcome after thrombolysis in acute ischemic stroke. Med Sci Monit. 2016;22:3268–3273. https://doi.org/https://doi.org/10.12659/msm.900010.
- Ling- C, Hong -Z, Yu W, et al. The serum homocysteine level in patients with acute ischemic stroke (AIS) after thrombolysis and its relationship with clinical outcomes. Rev Assoc Med Bras. (1992) 2018;64(5):438–442. https://doi.org/https://doi.org/10.1590/1806-9282.64.05.438.
- Tu WJ, Zhao SJ, Liu TG, et al. Combination of high-sensitivity C-reactive protein and homocysteine predicts the short-term outcomes of Chinese patients with acute ischemic stroke. Neurol Res. 2013;35(9):912–921. https://doi.org/https://doi.org/10.1179/1743132813Y.0000000228.
- Wu XQ, Ding J, Ge AY, et al. Acute phase homocysteine related to severity and outcome of atherothrombotic stroke. Eur J Intern Med. 2013;24(4):362–367. https://doi.org/https://doi.org/10.1016/j.ejim.2013.01.015.
- Anniwaer J, Liu MZ, Xue KD, et al. Homocysteine might increase the risk of recurrence in patients presenting with primary cerebral infarction. Int J Neurosci. 2019;129(7):654–659. https://doi.org/https://doi.org/10.1080/00207454.2018.1517762.
- Li L, Ma X, Zeng L, et al. Impact of homocysteine levels on clinical outcome in patients with acute ischemic stroke receiving intravenous thrombolysis therapy. PeerJ. 2020;8:e9474. https://doi.org/https://doi.org/10.7717/peerj.9474.
- Okubadejo NU, Oladipo OO, Adeyomoye AA, et al. Exploratory study of plasma total homocysteine and its relationship to short-term outcome in acute ischaemic stroke in Nigerians. BMC Neurol. 2008;8:26. https://doi.org/https://doi.org/10.1186/1471-2377-8-26.
- Cojocaru IM, Cojocaru M, Sapira V, et al. Evaluation of oxidative stress in patients with acute ischemic stroke. Rom J Intern Med. 2013;51(2):97–106.
- Song J, Park J, Oh Y, et al. Glutathione suppresses cerebral infarct volume and cell death after ischemic injury: involvement of FOXO3 inactivation and Bcl2 expression. Oxid Med Cell Longev. 2015;2015:426069. doi:https://doi.org/10.1155/2015/426069.
- Ivanov AV, Alexandrin VV, Paltsyn AA, et al. Plasma low-molecular-weight thiol/disulphide homeostasis as an early indicator of global and focal cerebral ischaemia. Redox Rep. 2017;22(6):460–466. https://doi.org/https://doi.org/10.1080/13510002.2017.1311464.
- Ivanov AV, Alexandrin VV, Paltsyn AA, et al. Metoprolol and nebivolol prevent the decline of the redox status of low-molecular-weight aminothiols in blood plasma of rats during acute cerebral ischemia. J Cardiovasc Pharmacol. 2018;72(4):195–203. https://doi.org/https://doi.org/10.1097/FJC.0000000000000616.
- Maksimova MY, Ivanov AV, Virus ED, et al. Disturbance of thiol/disulfide aminothiols homeostasis in patients with acute ischemic stroke stroke: preliminary findings. Clin Neurol Neurosurg. 2019;183(105393). https://doi.org/https://doi.org/10.1016/j.clineuro.2019.105393.
- Brott T, Adams HP Jr, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20(7):864–870. https://doi.org/https://doi.org/10.1161/01.str.20.7.864.
- Sulter G, Steen C, De Keyser J. Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke 1999;30:1538–1541.
- Brustolin S, Giugliani R, Félix TM. Genetics of homocysteine metabolism and associated disorders. Braz J Med Biol Res. 2010;43(1):1–7. https://doi.org/https://doi.org/10.1590/s0100-879 × 2009007500021.
- Harris S, Rasyid A, Kurniawan M, et al. Association of high blood homocysteine and risk of increased severity of ischemic stroke events. Int J Angiol. 2019;28(1):34–38.
- Martinez-Revelles S, Jiménez-Altayó F, Caracuel L, et al. Endothelial dysfunction in rat mesenteric resistance artery after transient middle cerebral artery occlusion. J Pharmacol Exp Ther. 2008;325(2):363–369. https://doi.org/https://doi.org/10.1124/jpet.107.134619.
- Kahl A, Stepanova A, Konrad C, et al. Critical role of flavin and glutathione in complex I-mediated bioenergetic failure in brain ischemia/reperfusion injury. Stroke. 2018;49(5):1223–1231. doi:https://doi.org/10.1161/STROKEAHA.117.019687.
- Chen C, Ding Q, Shen B, et al. Insights into the authentic active ingredients and action sites of oral exogenous glutathione in the treatment of ischemic brain injury based on pharmacokinetic-pharmacodynamic studies. Drug Metab Dispos. 2020;48(1):52–62. doi:https://doi.org/10.1124/dmd.119.089458.
- Sabetghadam M, Mazdeh M, Abolfathi P, et al. Evidence for a beneficial effect of oral N-acetylcysteine on functional outcomes and inflammatory biomarkers in patients with acute ischemic stroke. Neuropsychiatr Dis Treat. 2020;16:1265–1278. https://doi.org/https://doi.org/10.2147/NDT.S241497.
- Rebrin I, Sohal RS. Pro-oxidant shift in glutathione redox state during aging. Adv Drug Deliv Rev. 2008;60(13-14):1545–1552. doi:https://doi.org/10.1016/j.addr.2008.06.001.
- Zhu Y., Carvey P.M., Ling Z. Age-related changes in glutathione and glutathione-related enzymes in rat brain. Brain Res. 2006;1090:35–44. doi:https://doi.org/10.1016/j.brainres.2006.03.063.
- Maher P. The effects of stress and aging on glutathione metabolism. Ageing Res Rev. 2005 May;4(2):288–314. doi:https://doi.org/10.1016/j.arr.2005.02.005.
- Uemura T, Watanabe K, Ishibashi M, et al. Aggravation of brain infarction through an increase in acrolein production and a decrease in glutathione with aging. Biochem Biophys Res Commun. 2016;473(2):630–635. doi:https://doi.org/10.1016/j.bbrc.2016.03.137.
- Andersson A, Lindgren A, Hultberg B. Effect of thiol oxidation and thiol export from erythrocytes on determination of redox status of homocysteine and other thiols in plasma from healthy subjects and patients with cerebral infarction. Clin Chem. 1995;41(3):361–366.
- Andersson A, Hutlberg B, Lindgren A. Redox status of plasma homocysteine and other plasma thiols in stroke patients. Atherosclerosis. 2000;151(2):535–539.
- Williams RH, Maggiore JA, Reynolds RD, et al. Novel approach for the determination of the redox status of homocysteine and other aminothiols in plasma from healthy subjects and patients with ischemic stroke. Clin Chem. 2001;47(6):1031–1039.